CITIC Securities Company Limited
Regarding
Rayz Pharmaceutical Technology Co., Ltd.
2024 Issuance of Shares to Specific Targets
Issuance Sponsorship Letter
Sponsor (Lead Underwriter)
North Tower, Excellence Times Plaza (Phase II), No. 8 Central Third Road, Futian District, Shenzhen, Guangdong Province
July 2026
Declaration
This sponsor and its representatives have acted in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for the Registration of Securities Issuance by Listed Companies, the Administrative Measures for the Sponsorship of Securities Issuance and Listing, and other relevant laws, administrative regulations, and the rules of the China Securities Regulatory Commission and the Shenzhen Stock Exchange. We have acted with honesty, trustworthiness, and due diligence, strictly following established business rules, industry practice standards, and ethical codes to issue this sponsorship letter, and we guarantee the authenticity, accuracy, and completeness of the documents provided.
Table of Contents
Declaration 1
Table of Contents 2
Definitions 3
I. General Terms 3
II. Technical Terms 4
Section I Basic Information of the Securities Issuance 7
I. Information on Sponsor Project Personnel 7
II. Basic Information of the Issuer 7
III. Relationships and Major Business Dealings Between the Sponsor and its Affiliates and the Issuer and its Affiliates 8
IV. Internal Review Procedures and Opinions of the Sponsor 9
V. Verification of Paid Engagement of Third-Party Institutions and Individuals 10
Section II Sponsor's Commitments 11
Section III Recommendation Opinions on the Securities Issuance 12
I. Sponsor's Conclusion on the Issuance and Listing 12
II. Decision-making Procedures for the Issuance Comply with the Company Law and CSRC Regulations 12
III. The Issuance Meets the Conditions Stipulated by the Company Law 12
IV. The Issuance Meets the Conditions Stipulated by the Securities Law 13
V. The Issuance Meets the Conditions Stipulated by the Registration Management Measures 13
VI. The Issuance Meets the Conditions Stipulated by the Securities and Futures Legal Application Opinion No. 18 15
VII. Major Risks Faced by the Issuer 16
VIII. Development Prospects of the Issuer 19
Definitions
In this sponsorship letter, unless the context otherwise requires, the following abbreviations and terms have the following meanings: